OS Therapies Incorporated
OS Therapies Incorporated (OSTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OSTX · as of Jun 9, 2026
Key Statistics
Explore OS Therapies Incorporated Data
ostx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
ostx competitorsOSTX
ADAG
COEP
CRVO
EQ
HOWLStock Performance
Full HistoryAbout OS Therapies Incorporated
OS Therapies Incorporated is a clinical-stage biopharmaceutical company dedicated to identifying, advancing, and commercializing therapeutic solutions for osteosarcoma and other solid tumors within th…
what is os therapies incorporated · ostx stock overview · os therapies incorporated company profile · who is os therapies incorporated ceo · ostx AMEX · os therapies incorporated headquarters · os therapies incorporated business segments
About Stock Overview & Key Data
OS Therapies Incorporated (OSTX) is a Healthcare company in the Biotechnology industry, listed on AMEX since Aug 1, 2024. As of the latest trading session, OSTX stock price is $1.79, with a market capitalization of $79.7M. The stock has returned -9.60% over the past 12 months and +27.86% year-to-date.
According to 4 Wall Street analysts, the consensus rating for OS Therapies Incorporated stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, OS Therapies Incorporated reported revenue of — and net income of -$28.8M. For detailed data — including OS Therapies Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, OS Therapies Incorporated (OSTX) stock price is $1.79. The stock is traded on AMEX under the ticker symbol OSTX. The 52-week range is $1.15 – $2.57.